Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Nanomedicine : Nanotechnology, Biology, and Medicine|February 26, 2014
Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluidsJia Fan, Shiwen Niu, Ailian Dong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2019
Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFEEdouard Bardou-Jacquet, Emilie Morandeau, Gregory J Anderson, et al.
The American Journal of Clinical Nutrition|February 4, 2012
Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han populationWei Gan, Yu Guan, Qian Wu, et al.
ACS Nano|January 25, 2019
Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor GrowthJiayan Lang, Xiao Zhao, Xiuchao Wang, et al.
Blood|January 31, 2004
Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia miceHuijun Chen, Zouhair K Attieh, Trent Su, et al.
Genome Biology|December 23, 2008
A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in developmentAlyson Ashe, Daniel K Morgan, Nadia C Whitelaw, et al.
Plos Genetics|May 25, 2019
Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotypePrashant Sharma, Marie Reichert, Yan Lu, et al.
Scientific Reports|July 20, 2021
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosisSim Yee Ong, Tiffany Khoo, Amanda J Nicoll, et al.
Science Translational Medicine|July 8, 2021
Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccinesLong Chen, Hao Qin, Ruifang Zhao, et al.
Nature Biomedical Engineering|April 25, 2019
Author Correction: Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumoursSuping Li, Yinlong Zhang, Jing Wang, et al.
Pageof 19